Diabetes & Metabolism Journal

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

What Is the Optimal Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients?: The Practical Evidence of Antidiabetic Monotherapy Study

Ji Hun Choi, Won-Young Lee

Diabetes Metab J. 2011;35(1):23-25. Published online February 28, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.1.23

What Is the Optimal Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients?: The Practical Evidence of Antidiabetic Monotherapy Study

Ji Hun Choi, Won-Young Lee

Diabetes & Metabolism Journal. 2011;35(1):23

Link1 Link2 Link3

Comparison of the Efficacy of Glimepiride, Metformin, and Rosiglitazone Monotherapy in Korean Drug-Naïve Type 2 Diabetic Patients: The Practical Evidence of Antidiabetic Monotherapy Study

Kun Ho Yoon, Jeong Ah Shin, Hyuk Sang Kwon, Seung Hwan Lee, Kyung Wan Min, Yu Bae Ahn, Soon Jib Yoo, Kyu Jeung Ahn, Sung Woo Park, Kwan Woo Lee, Yeon Ah Sung, Tae Sun Park, Min Seon Kim, Yong Ki Kim, Moon Suk Nam, Hye Soon Kim, Ie Byung Park, Jong Suk Park, Jeong Taek Woo, Ho Young Son

Diabetes & Metabolism Journal. 2011;35(1):26

Link1 Link2 Link3

Cancer Risk in Patients with Type 2 Diabetes on Antidiabetic Monotherapy: A Population Based Cohort Study Using National Insurance Health Service Database

Han Yeong Jung, Sukhyang Lee

Korean Journal of Clinical Pharmacy. 2019;29(3):186-192

Link1

Risk of cardiovascular diaseases associated with antidiabetic monotherapy intervals in type-2 diabetic patients – A preliminiary study on taiwan pay-for-performance diabetes registry

X.Q. Zhang, S. Zhu, L.C. Chen, L.J. Cheng

Value in Health. 2013;16(3):A158

Link1 Link2

Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes

F. Xavier Pi-Sunyer, Anja Schweizer, David Mills, Sylvie Dejager

Diabetes Research and Clinical Practice. 2007;76(1):132-138

Link1 Link2

Regulation of Free Fatty Acid by Sitagliptin Monotherapy in DRUG-NAÏVE Subjects with Type 2 Diabetes

Eiji Kutoh, Asuka Wada, Jyunka Hayashi

Endocrine Practice. 2018;24(12):1063-1072

Link1 Link2

A comparative study on efficacy of fixed combination timolol/brinzolamide versus travoprost monotherapy in drug-naïve open-angle glaucoma patients

Alok Dixit, Atul Ashish, Reena Sharma

Therapeutic Advances in Ophthalmology. 2020;12:251584142090966

Link1 Link2 Link3

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug—naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study

T MORETTO, D MILTON, T RIDGE, L MACCONELL, T OKERSON, A WOLKA, R BRODOWS

Clinical Therapeutics. 2008;30(8):1448-1460

Link1 Link2

Monotherapy in Type 2 Diabetes Mellitus Patients 2017: A Position Statement of the Korean Diabetes Association

Sang Youl Rhee

The Journal of Korean Diabetes. 2018;19(1):15

Link1 Link2 Link3

PDB18 COMPARISON OF RESOURCES UTILIZATION (RU)AND COST IN DRUG NAÏVE TYPE 2 DIABETES (T2D) PATIENTS TREATED WITH ROSIGLITAZONE (RSG)VS. SULFONYLUREA (SU) MONOTHERAPY

MS Duh, A Gosselin, N Beaulieu, LM Arana, B Arondekar

Value in Health. 2008;11(3):A223

Link1 Link2